| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/08/2008 | US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof |
| 01/08/2008 | US7317086 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering |
| 01/08/2008 | US7317004 fusing cells: nucleic acid vector comprises a nucleotide sequence encoding a syncytium-inducing polypeptide that is expressible on a eukaryotic cell surface and comprises a sequence of a gibbon ape leukemia virus |
| 01/08/2008 | US7316925 Codon optimized synthetic plasmids |
| 01/08/2008 | US7316923 Compositions and methods for non-targeted activation of endogenous genes |
| 01/08/2008 | US7316915 Polypeptide for use in the treatment of apoptitic disorders |
| 01/08/2008 | US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 01/08/2008 | US7316907 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 01/08/2008 | US7316898 Method of determining adenovirus particle concentration |
| 01/08/2008 | US7316812 Cells expressing anti-Fc receptor binding components |
| 01/08/2008 | CA2331781C De novo dna cytosine methyltransferase genes, polypeptides and uses thereof |
| 01/08/2008 | CA2324028C Retroviral packaging cell line |
| 01/08/2008 | CA2271929C Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 01/03/2008 | WO2008002678A2 Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use |
| 01/03/2008 | WO2008000186A1 A method for identifying novel gene and the resulting novel genes |
| 01/03/2008 | WO2008000079A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | WO2007080457A3 Use of inhibitors of scinderin and/or of ephrin-a1 for treating tumors |
| 01/03/2008 | WO2007075845A3 Isolated mcpip and methods of use |
| 01/03/2008 | WO2007068478A8 Rna helicase as marker for rare tumours |
| 01/03/2008 | WO2007006581A3 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/03/2008 | WO2005047505A3 Methods and products for expression of micro rnas |
| 01/03/2008 | WO2005032476A3 Methods and compositions for cpg15-2 |
| 01/03/2008 | WO2005007196A3 Lipid encapsulated interfering rna |
| 01/03/2008 | WO2004060323A3 Novel inhibitors of poxvirus replication |
| 01/03/2008 | WO2003085085A3 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| 01/03/2008 | US20080004234 System for delivering therapeutic agents into living cells and cells nuclei |
| 01/03/2008 | US20080004231 Disease-Associated Protein |
| 01/03/2008 | US20080004230 SAM Riboswitch and Uses Thereof |
| 01/03/2008 | US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level |
| 01/03/2008 | US20080004208 Methods for Diagnosis and Prognosis of Malignant Lymphoma |
| 01/03/2008 | US20080003683 Ce7-specific redirected immune cells |
| 01/03/2008 | US20080003682 treatment or prevention of infection through the expression of one or more RNA molecules that inhibit one or more aspects of the life cycle of a pathogen through RNA interference with a target nucleic acid; for human lymphadenopathy associated viral diseases |
| 01/03/2008 | US20080003658 Method for expression of small antiviral rna molecules within a cell |
| 01/03/2008 | US20080003221 Compositions and methods for treating inflammatory lung disease |
| 01/03/2008 | US20080003212 ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor |
| 01/03/2008 | US20080003206 ABCB5 positive mesenchymal stem cells as immunomodulators |
| 01/03/2008 | US20080003204 Compositions and methods for treating cystic fibrosis |
| 01/03/2008 | US20080003203 Pseudotyped baculovirus to stimulate immunogenicity against avian influenza |
| 01/03/2008 | DE60219221T2 DNS-Sequenzen mit anti-repressor Aktivität DNA sequences with anti-repressor activity |
| 01/03/2008 | DE102006030366A1 Pharmaceutical composition useful for treating Parkinson's disease comprises a substance that specifically interacts with a homer1 gene |
| 01/03/2008 | CA2653756A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873240A1 hTERT GENE EXPRESSION REGULATORY GENE |
| 01/02/2008 | EP1871890A2 Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject |
| 01/02/2008 | EP1871888A2 Haemophilus influenzae type b |
| 01/02/2008 | EP1871881A2 Metabolic-based methods for modulating gene expression |
| 01/02/2008 | EP1641491B1 Increased t-cell tumor infiltration by mutant light |
| 01/02/2008 | EP1448223B1 Thymosin augmentation of genetic immunization |
| 01/02/2008 | EP1290156B1 Purification of a triple helix formation with an immobilized oligonucleotide |
| 01/02/2008 | EP1252307B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/02/2008 | EP1129177B1 Avipox vector coding an hiv antigen and gamma-interferon |
| 01/02/2008 | EP0942934B1 Receptor tyrosine kinase genes |
| 01/02/2008 | EP0920514B1 Targeting adenovirus with use of constrained peptide motifs |
| 01/02/2008 | EP0863987B1 Vectors and methods for gene transfer to cells |
| 01/02/2008 | CN101098882A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 01/02/2008 | CN101096686A Recombined chicken poxviral active carrier vaccine rFPV-1218NDHN for expression of newcastle disease virus HN gene and its constructing method |
| 01/02/2008 | CN101096685A Recombined chicken poxviral active carrier vaccine rFPV-1218NDF for expression of newcastle disease virus F gene and its constructing method |
| 01/02/2008 | CN101096680A NDA vaccine eucaryon expression carrier and application in preparation of gene vaccine |
| 01/02/2008 | CN101096670A siRNA interfering human a-fetoprotein gene and recombinant adenovirus |
| 01/02/2008 | CN101096386A Dectin-1 and heat shock protein Hsp60 polymer and coding nucleic acid and application thereof |
| 01/02/2008 | CN101095957A Medicinal composition including fibroblast growth factor acceptor 2 ó¾ c analogue gene |
| 01/02/2008 | CN101095953A Treating cancer through attracting effect T cell and loss regulating T cell |
| 01/02/2008 | CN101095951A Therapeutic HBV DNA vaccines, method for preparing the same and application thereof |
| 01/02/2008 | CN100359015C Human tumour-derived polyptde hormone phosphatonin |
| 01/02/2008 | CN100359004C Natural killer cell for transgenic expression cell chemotactic factors |
| 01/02/2008 | CN100358919C Mammal prolactin variants |
| 01/02/2008 | CN100358581C Drug- or gene-carrier composition having lowered hemagglutinin activity |
| 01/01/2008 | US7314956 A molecular carrier containing a central multivalent core and multiple adduct molecules bonded with core, wherein adduct represents adduct moieties which can be the same of different from one another and are residues of amino acids |
| 01/01/2008 | US7314927 Anticode oligomer for prevention and treatment of cell proliferative disorders; antitumor, antisense, antiproliferative agents |
| 01/01/2008 | US7314926 Inhibiting cell proliferation, breast cancer, prostate cancer, cervical cancer, lung cancer, or tumor cells |
| 01/01/2008 | US7314923 The present invention relates to novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer |
| 01/01/2008 | US7314919 Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 01/01/2008 | US7314868 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 01/01/2008 | US7314865 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening |
| 01/01/2008 | US7314864 Isolated polypeptid of 24-amino acids; the clone suppressed neuronal death induced by all of the known types of early-onset familial Altzheimers Disease genes |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314628 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 12/30/2007 | CA2558160A1 Antisense oligonucleotides for treatment of muscle wasting |
| 12/27/2007 | WO2007149817A2 Combinations of biological control agents with a nematicidal seed coating |
| 12/27/2007 | WO2007149518A2 Dna composition against tumor stromal antigen fap and methods of use thereof |
| 12/27/2007 | WO2007149493A2 Restoration of hearing loss |
| 12/27/2007 | WO2007149433A2 Tumor-specific delivery of therapeutic agents via liposomase |
| 12/27/2007 | WO2007149312A2 Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph |
| 12/27/2007 | WO2007149115A1 Methods for treating target joints in inflammatory arthritis using aav vectors encoding a tnf antagonist |
| 12/27/2007 | WO2007148609A1 Ex vivo/in vivo proliferation of hematopoietic stem cell or hematopoietic progenitor cell by timp-3 |
| 12/27/2007 | WO2007148326A2 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
| 12/27/2007 | WO2007147528A1 Process for producing poxviruses and poxvirus compositions |
| 12/27/2007 | WO2007147265A1 Polynucleotides and polypeptide sequences involved in cancer |
| 12/27/2007 | WO2007130604A3 Anti-tumor activity of an oncolytic adenovirus-delivered oncogene sirna |
| 12/27/2007 | WO2007103549A3 Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders |
| 12/27/2007 | WO2007087462A3 Methods and compositions for cancer therapy using a novel adenovirus |
| 12/27/2007 | WO2007050128A3 Shielded adenoviral vectors and methods of use |
| 12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
| 12/27/2007 | US20070299097 Strategy for Leukemia Therapy |
| 12/27/2007 | US20070299031 Therapeutic agent for tumor of neural origin |
| 12/27/2007 | US20070299030 MicroRNA biomarkers for human breast and lung cancer |
| 12/27/2007 | US20070299028 Backbone modifications to modulate oligonucleotide targeting in vivo |